foxo4 dri senolytic peptide study 2017 cell

foxo4 dri senolytic peptide study 2017 cell The disordered p53 transactivation domain is the target of and the compound FOXO4-DRI Frontiers | FOXO4-DRI regulates endothelial

Name: foxo4 dri senolytic peptide study 2017 cell The disordered p53 transactivation domain is the target of and the compound FOXO4-DRI Frontiers | FOXO4-DRI regulates endothelial
Brand: tmdnewgeneration.cz
SKU: 59545865872
Price: 27.03 USD
Availability: InStock
Rating: 4.6309000000000005 (28 reviews)

Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway FOXO4 DRI: The Senolytic Peptide That Targets Zombie Cells and Aging Revolution Health & Wellness Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv

SKU: 59545865872 · From tmdnewgeneration.cz

4.6

USD27.03 USD62.03

Pay in 4 interest-free payments of $6.76 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Nov 7 - Nov 12

Description

NNMT catalyzes the transfer of a methyl group from S-adenosyl-L-methionine to nicotinamide, influencing intracellular nicotinamide availability and interacting with NAD-associated metabolic processes